Cargando…

Severe bradycardia in critically ill patients with COVID-19 – A cases report

INTRODUCTION: Cardiac injury has been reported as an important manifestation of coronavirus disease 2019 (COVID-19) and arrhythmic events are common. Here, we report a case series of severe sinus bradycardia among patients hospitalized in intensive care units (ICU) with COVID-19. OBJECTIVE AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Larue, J., Dejode, P., Timsit, J.F., Franchineau, G., Extramiana, F., Algalarrondo, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 2021
Materias:
340
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127553/
http://dx.doi.org/10.1016/j.acvdsp.2021.04.203
_version_ 1783693970086297600
author Larue, J.
Dejode, P.
Timsit, J.F.
Franchineau, G.
Extramiana, F.
Algalarrondo, V.
author_facet Larue, J.
Dejode, P.
Timsit, J.F.
Franchineau, G.
Extramiana, F.
Algalarrondo, V.
author_sort Larue, J.
collection PubMed
description INTRODUCTION: Cardiac injury has been reported as an important manifestation of coronavirus disease 2019 (COVID-19) and arrhythmic events are common. Here, we report a case series of severe sinus bradycardia among patients hospitalized in intensive care units (ICU) with COVID-19. OBJECTIVE AND METHOD: From January to May 2020, 113 patients were admitted in ICU for severe COVID-19. All these patients underwent continuous monitoring of their cardiac rhythm. Ten patients (9%) presented a bradycardia. A 24-hour Holter-ECG was subsequently performed for 7 patients. RESULTS: Patients had a median age of 63 years. Most of them were men and had severe acute respiratory distress syndrome. All episodes were due to sinus bradycardia with a median heart rate of 36 bpm. Bradycardia was sudden for four patients and required brief resuscitation maneuvers for one. Bradycardia was persistent for the six other patients and required transient continuous isoprenaline infusion for three. Patients had normal baseline ECG and echocardiography. A comprehensive review of patient's files ruled out bradycardia due to drug-drug interactions, myocarditis, hyperkalemia, hypoxia or vagal physical stimulation. Two patients had beta-blockers interrupted several days before bradycardia and one patient received Hydroxychloroquine discontinued 21 days before bradycardia. On the Holter-ECG, 3 recordings evoked vagal hyperactivity (low mean heart rate and elevated pNN50/RMSSD, Fig. 1, patient A), 3 others cardiac dysautonomia (SDNN < 100 ms, Fig. 1, patient B). Amongst these 10 patients, five returned home and five died from COVID-19 associated multiple-organ failure. None of them required temporary or permanent cardiac pacing (Fig. 1). CONCLUSION: We hypothesized that bradycardia may be due to an autonomic nervous system injury. The parallel course of COVID-19 and bradycardia suggest that these patients do not have intrinsic sinus node disease and that pacemaker implantation should not be recommended.
format Online
Article
Text
id pubmed-8127553
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Masson SAS
record_format MEDLINE/PubMed
spelling pubmed-81275532021-05-18 Severe bradycardia in critically ill patients with COVID-19 – A cases report Larue, J. Dejode, P. Timsit, J.F. Franchineau, G. Extramiana, F. Algalarrondo, V. Archives of Cardiovascular Diseases. Supplements 340 INTRODUCTION: Cardiac injury has been reported as an important manifestation of coronavirus disease 2019 (COVID-19) and arrhythmic events are common. Here, we report a case series of severe sinus bradycardia among patients hospitalized in intensive care units (ICU) with COVID-19. OBJECTIVE AND METHOD: From January to May 2020, 113 patients were admitted in ICU for severe COVID-19. All these patients underwent continuous monitoring of their cardiac rhythm. Ten patients (9%) presented a bradycardia. A 24-hour Holter-ECG was subsequently performed for 7 patients. RESULTS: Patients had a median age of 63 years. Most of them were men and had severe acute respiratory distress syndrome. All episodes were due to sinus bradycardia with a median heart rate of 36 bpm. Bradycardia was sudden for four patients and required brief resuscitation maneuvers for one. Bradycardia was persistent for the six other patients and required transient continuous isoprenaline infusion for three. Patients had normal baseline ECG and echocardiography. A comprehensive review of patient's files ruled out bradycardia due to drug-drug interactions, myocarditis, hyperkalemia, hypoxia or vagal physical stimulation. Two patients had beta-blockers interrupted several days before bradycardia and one patient received Hydroxychloroquine discontinued 21 days before bradycardia. On the Holter-ECG, 3 recordings evoked vagal hyperactivity (low mean heart rate and elevated pNN50/RMSSD, Fig. 1, patient A), 3 others cardiac dysautonomia (SDNN < 100 ms, Fig. 1, patient B). Amongst these 10 patients, five returned home and five died from COVID-19 associated multiple-organ failure. None of them required temporary or permanent cardiac pacing (Fig. 1). CONCLUSION: We hypothesized that bradycardia may be due to an autonomic nervous system injury. The parallel course of COVID-19 and bradycardia suggest that these patients do not have intrinsic sinus node disease and that pacemaker implantation should not be recommended. Published by Elsevier Masson SAS 2021-05 2021-05-17 /pmc/articles/PMC8127553/ http://dx.doi.org/10.1016/j.acvdsp.2021.04.203 Text en Copyright © 2021 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 340
Larue, J.
Dejode, P.
Timsit, J.F.
Franchineau, G.
Extramiana, F.
Algalarrondo, V.
Severe bradycardia in critically ill patients with COVID-19 – A cases report
title Severe bradycardia in critically ill patients with COVID-19 – A cases report
title_full Severe bradycardia in critically ill patients with COVID-19 – A cases report
title_fullStr Severe bradycardia in critically ill patients with COVID-19 – A cases report
title_full_unstemmed Severe bradycardia in critically ill patients with COVID-19 – A cases report
title_short Severe bradycardia in critically ill patients with COVID-19 – A cases report
title_sort severe bradycardia in critically ill patients with covid-19 – a cases report
topic 340
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127553/
http://dx.doi.org/10.1016/j.acvdsp.2021.04.203
work_keys_str_mv AT laruej severebradycardiaincriticallyillpatientswithcovid19acasesreport
AT dejodep severebradycardiaincriticallyillpatientswithcovid19acasesreport
AT timsitjf severebradycardiaincriticallyillpatientswithcovid19acasesreport
AT franchineaug severebradycardiaincriticallyillpatientswithcovid19acasesreport
AT extramianaf severebradycardiaincriticallyillpatientswithcovid19acasesreport
AT algalarrondov severebradycardiaincriticallyillpatientswithcovid19acasesreport